Sergio Giralt

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Qing He, Mithat Gonen, Michel Sadelain, 2014, Science Translational Medicine.

Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome

Krishna Komanduri, Hoang Q. Nguyen, Marcos de Lima, 2010, Cancer.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

James Allison, Stephen Forman, Massimo Cristofanilli, 2015, Mayo Clinic proceedings.

Complete Remission Represents the Major Surrogate Marker of Long Survival in Multiple Myeloma.

Michael Wang, Michael L. Wang, Sheeba K. Thomas, 2006 .

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

Hartmut Goldschmidt, Meral Beksaç, Mario Boccadoro, 2011, Blood.

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

John P Klein, Daniel J Weisdorf, J. Klein, 2002, Blood.

Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high‐risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation

Russell E. Lewis, Xin Han, Jorge Cortes, 2007, Cancer.